Engineered nanoparticles for endocrine tumor targeting, current progress and future outlook
- 문서 유형
- 연구출판물 · 리뷰논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q2
- 저널
- MEDICAL ONCOLOGY43(2) · 2026
- 피인용
- Web of Science 0Scopus 0
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2024 3.5
- ISSN
- 1357-0560
저자
- Aftab, Maryam제1저자COMSATS Univ, Dept Biosci, Pk Rd, Islamabad 45520, Pakistan
- Ahmed, ZubairKohat Univ Sci & Technol, Dept Pharm, Kohat 26000, Khyber Pakhtunk, Pakistan
- 무닙 울라Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
- Khan, Shahid UllahDubai Med Univ, Coll Med, Dept Biomed Sci, COM,DMU, Dubai 19099, U Arab Emirates
- Naeem, MuhammadNatl Univ Med Sci, Dept Biol Sci, Islamabad 46000, Pakistan
- Khan, AmjadKohat Univ Sci & Technol, Dept Pharm, Kohat 26000, Khyber Pakhtunk, Pakistan
- Wahab, Abdul교신저자Kohat Univ Sci & Technol, Dept Pharm, Kohat 26000, Khyber Pakhtunk, Pakistan
초록
Endocrine tumors are hormone-secreting tumors that pose significant challenges for diagnosis and treatment due to their complex biological processes, delayed detection, and poor response to existing therapies. Despite advancements in imaging, surgery, and medicine, tumor heterogeneity, substantial barriers, and systemic toxicity hinder therapeutic success. A novel approach utilizing nanotechnology presents theranostics capabilities for various applications, enhances bioavailability, and ensures precise drug delivery. Engineered nanoparticles (NPs), including lipid-based, polymeric, and inorganic nanocarriers, enable targeted therapy through active targeting (ligand-receptor interactions) or passive accumulation (increased permeability and retention). These nanotechnologies address drug resistance and rapid clearance, delivering treatments directly to tumors while minimizing adverse effects on healthy cells. NPs that mimic biological processes or respond to external stimuli can adapt to the evolving tumor microenvironment. This review focuses on NP-based therapy for endocrine cancer, discussing their mechanisms of action, targeted approaches, and diagnostic and therapeutic applications. The limitations of current therapies and the future prospects of NP-based therapies are explored.
키워드
Endocrine tumorsEngineered nanoparticlesNanotechnologyTargeting tumors
식별자
- Scopus EID
- 2-s2.0-105025855566
- WoS UID
- 001649812700004



로그인
연구물 목록으로